Smith And Sapphire Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 07-01-2025
- Paid Up Capital ₹ 4.00 Cr
as on 07-01-2025
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2011
- Open Charges ₹ 1.84 Cr
as on 07-01-2025
About Smith And Sapphire Bio-Tech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2011. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company currently has active open charges totaling ₹1.84 Cr.
Rohit Kumar, Mahmud Kazi, and Dilip Pandey serve as directors at the Company.
- CIN/LLPIN
U74899DL1995PLC065063
- Company No.
065063
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Feb 1995
- Date of AGM
28 Sep 2011
- Date of Balance Sheet
31 Mar 2011
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Smith And Sapphire Bio-Tech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Kumar  | Director | 28-May-2016 | Current |
| Mahmud Kazi | Director | 28-May-2016 | Current |
| Dilip Pandey | Director | 28-May-2016 | Current |
Financial Performance of Smith And Sapphire Bio-Tech.
Enhance accessibility to Smith And Sapphire Bio-Tech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Smith And Sapphire Bio-Tech?
Unlock access to Smith And Sapphire Bio-Tech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.84 Cr
₹0
Charges Breakdown by Lending Institutions
- Oriental Bank Of Commerce : 1.04 Cr
- Punjab National Bank : 0.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Aug 2013 | Oriental Bank Of Commerce | ₹1.44 M | Open |
| 12 Dec 2012 | Oriental Bank Of Commerce | ₹9.00 M | Open |
| 24 Oct 2009 | Punjab National Bank | ₹8.00 M | Open |
How Many Employees Work at Smith And Sapphire Bio-Tech?
Unlock and access historical data on people associated with Smith And Sapphire Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Smith And Sapphire Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Smith And Sapphire Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
